↓ Skip to main content

Communication Bridge™-2 (CB2): an NIH Stage 2 randomized control trial of a speech-language intervention for communication impairments in individuals with mild to moderate primary progressive aphasia

Overview of attention for article published in Trials, June 2022
Altmetric Badge

Mentioned by

twitter
6 X users

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
53 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Communication Bridge™-2 (CB2): an NIH Stage 2 randomized control trial of a speech-language intervention for communication impairments in individuals with mild to moderate primary progressive aphasia
Published in
Trials, June 2022
DOI 10.1186/s13063-022-06162-7
Pubmed ID
Authors

Angela C. Roberts, Alfred W. Rademaker, Elizabeth Ann Salley, Aimee Mooney, Darby Morhardt, Melanie Fried-Oken, Sandra Weintraub, Marsel Mesulam, Emily Rogalski

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 53 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 53 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 6 11%
Researcher 5 9%
Unspecified 4 8%
Student > Master 4 8%
Lecturer 3 6%
Other 8 15%
Unknown 23 43%
Readers by discipline Count As %
Nursing and Health Professions 6 11%
Medicine and Dentistry 5 9%
Psychology 5 9%
Unspecified 4 8%
Business, Management and Accounting 3 6%
Other 5 9%
Unknown 25 47%